ClinicalThought

Share

Program Content

Activities

  • Individualizing EBC Treatment
    Improving Outcomes in HER2-Negative Early Breast Cancer With Individualized Targeted Approaches
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: June 21, 2023

  • HER2-Negative EBC Tool Update
    As the Treatment of HER2-Negative Early Breast Cancer Evolves, So Does Our Corresponding Treatment Decision Support Tool
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: October 11, 2023

Faculty

cover img faculity

Laura M. Spring, MD

Breast Medical Oncologist
Mass General Hospital Cancer Center
Harvard Medical School
Boston, Massachusetts

Provided by

ProCE Banner

Supporters

Supported by educational grants from AstraZeneca and Merck Sharp & Dohme LLC.

AstraZeneca

Merck Sharp & Dohme, LLC

Partners

Smart Patients

ProCE Banner